SUZANNE FANELLI: Open Payments
NPI 1588712699 · MASSAPEQUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 31 payments from 10 companies in 2025. Trend: 2023 $487 · 2024 $918 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $145 |
| Esperion Therapeutics, Inc. | 5 | $103 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| Amgen Inc. | 4 | $81 |
| Boston Scientific Corporation | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Novo Nordisk Inc | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: VERQUVO, NEXLETOL, LEQVIO, WATCHMAN FLX, REPATHA, JARDIANCE, Rybelsus, FUROSCIX.
Industry payments across NY — which companies pay providers there.
